China, Merck and HPV
Barchart on MSN3h
What to Expect From Merck & Co.'s Q4 2024 Earnings ReportWith a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...
The stock's fall snapped a two-day winning streak.
Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).
This was the stock's second consecutive day of gains.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients, marking ...
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...
Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best low volatility stocks to buy right now. The market has shown strong performance overall ...
24/7 Wall St. on MSN2d
Merck Just Paid Investors: How Much Did They Receive?Merck & Co. Inc. (NYSE: MRK) is rewarding its shareholders once again with a quarterly dividend of $0.81 per share, payable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback